Related references
Note: Only part of the references are listed.Ending the HIV epidemic in the USA: an economic modelling study in six cities
Bohdan Nosyk et al.
LANCET HIV (2020)
Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact
Mark C. Bates et al.
CLINICAL CARDIOLOGY (2019)
Infective Endocarditis in Injection Drug Users A Recurrent Disease
Gilbert Habib et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Management of opioid use disorder in the USA: present status and future directions
Carlos Blanco et al.
LANCET (2019)
Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics Response
Sandra A. Springer et al.
ANNALS OF INTERNAL MEDICINE (2019)
Opioids and Infectious Diseases: A Converging Public Health Crisis
Tara A. Schweiz et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic
Michael A. Irvine et al.
ADDICTION (2019)
Developing a dynamic HIV transmission model for 6 US cities: An evidence synthesis
Emanuel Krebs et al.
PLOS ONE (2019)
DAG-informed regression modelling, agent-based modelling and microsimulation modelling: a critical comparison of methods for causal inference
Kellyn F. Arnold et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada
Laura MacDougall et al.
PLOS ONE (2019)
Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs
Sedona Sweeney et al.
ADDICTION (2019)
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Qiushi Chen et al.
JAMA NETWORK OPEN (2019)
Establishment of a comprehensive drug overdose fatality surveillance system in Kentucky to inform drug overdose prevention policies, interventions and best practices
Sarah L. Hargrove et al.
INJURY PREVENTION (2018)
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
Marc R. Larochelle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
Hannah Fraser et al.
JOURNAL OF HEPATOLOGY (2018)
Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models
Oguzhan Alagoz et al.
MEDICAL DECISION MAKING (2018)
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016
Hawre Jalal et al.
SCIENCE (2018)
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis
Joshua A. Barocas et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
State variation in opioid treatment policies and opioid-related hospital readmissions
Janice Blanchard et al.
BMC HEALTH SERVICES RESEARCH (2018)
Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study
Michael A. Irvine et al.
LANCET PUBLIC HEALTH (2018)
Effects of naloxone distribution to likely bystanders: Results of an agent based model
Christopher Keane et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2018)
Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
Emanuel Krebs et al.
ANNALS OF INTERNAL MEDICINE (2018)
Primary Care-Based Models for the Treatment of Opioid Use Disorder A Scoping Review
P. Todd Korthuis et al.
ANNALS OF INTERNAL MEDICINE (2017)
Association Between Dehydration and Short-Term Risk of Ischemic Stroke in Patients with Atrial Fibrillation
Joel N. Swerdel et al.
TRANSLATIONAL STROKE RESEARCH (2017)
Economic evaluation of an implementation strategy for the management of low back pain in general practice
Cathrine Elgaard Jensen et al.
PAIN (2017)
Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise
Janne C. Mewes et al.
VALUE IN HEALTH (2017)
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference
Eleanor J. Murray et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)
The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California
Emanuel Krebs et al.
ADDICTION (2017)
Quality of life as an outcome of opioid use disorder treatment: A systematic review
Jeremy W. Bray et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2017)
Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada
Eva A. Enns et al.
ADDICTION (2016)
Integrated knowledge translation (IKT) in health care: a scoping review
Anna R. Gagliardi et al.
IMPLEMENTATION SCIENCE (2016)
Calibrating Parameters for Microsimulation Disease Models: A Review and Comparison of Different Goodness-of-Fit Criteria
Alex van der Steen et al.
MEDICAL DECISION MAKING (2016)
Best-worst multi-criteria decision-making method: Some properties and a linear model
Jafar Rezaei
OMEGA-INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE (2016)
Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?
Sophie Whyte et al.
VALUE IN HEALTH (2016)
Short term health-related quality of life improvement during opioid agonist treatment
B. Nosyk et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment
Brandon Aden et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Best-worst multi-criteria decision-making method
Jafar Rezaei
OMEGA-INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE (2015)
Identifying Future Research Priorities Using Value of Information Analyses: Left Atrial Appendage Occlusion Devices in Atrial Fibrillation
Andrew Micieli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Value of Information Analysis in Oncology: The Value of Evidence and Evidence of Value
Haitham W. Tuffaha et al.
JOURNAL OF ONCOLOGY PRACTICE (2014)
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010
Louisa Degenhardt et al.
LANCET (2013)
The Economic Burden of Opioid-Related Poisoning in the United States
Timothy J. Inocencio et al.
PAIN MEDICINE (2013)
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment
Bohdan Nosyk et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model
Gary A. Zarkin et al.
HEALTH ECONOMICS (2012)
Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6
Andrew H. Briggs et al.
MEDICAL DECISION MAKING (2012)
Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
Lauren E. Cipriano et al.
PLOS ONE (2012)
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5
Richard Pitman et al.
VALUE IN HEALTH (2012)
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
Mark Roberts et al.
VALUE IN HEALTH (2012)
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Uwe Siebert et al.
VALUE IN HEALTH (2012)
Bayesian evidence synthesis for a transmission dynamic model for HIV among men who have sex with men
A. M. Presanis et al.
BIOSTATISTICS (2011)
Prioritizing Pharmacogenetic Research: A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment
Beth Woods et al.
VALUE IN HEALTH (2011)
Methods of Model Calibration Observations from a Mathematical Model of Cervical Cancer
Douglas C. A. Taylor et al.
PHARMACOECONOMICS (2010)
Comparative Effectiveness, Personalized Medicine and Innovation The Path Forward
Adrian Thomas et al.
PHARMACOECONOMICS (2010)
The Value of Value of Information Best Informing Research Design and Prioritization Using Current Methods
Simon Eckermann et al.
PHARMACOECONOMICS (2010)
Economic Burden of Prescription Opioid Misuse and Abuse
Scott A. Strassels
JOURNAL OF MANAGED CARE PHARMACY (2009)
Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
Natasha K. Stout et al.
PHARMACOECONOMICS (2009)
Optimal sample size determinations from an industry perspective based on the expected value of information
Andrew R. Willan
CLINICAL TRIALS (2008)
Modelling methods for pharmacoeconomics and health technology assessment - An overview and guide
James E. Stahl
PHARMACOECONOMICS (2008)
The value of information and optimal clinical trial design
AR Willan et al.
STATISTICS IN MEDICINE (2005)
Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation
AT McLellan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
